A new drug was approved earlier this week that will reduce a double chin back down to its original single-chin state. The drug is DCA, Deoxycholic acid, and it’s injected directly into the double chin. The drug then goes to work destroying the fat cell membranes to reduce the size of the double chin.
A study of the new drug has been conducted in three separate trial in the United States and Canada and involved over 1,000 patients. Chin fat was graded from 0-4, 4 being the extreme end of submental convexity (chin fat) and 0 being no chin fat at all. Most test subjects who started out with chin fat saw at least a two-grade reduction in their double chin.